IP Library Granted Patent US 12,214,067
Granted Patent B2
US 12,214,067 · App. 15/115,479 · Granted Feb 4, 2025

Oil-in-water emulsion sunscreen composition

Inventors: Diane M. Kennedy (Bayonne, NJ); Donald I. Prettypaul (Englewood, NJ); Hani M. Fares (Somerset, NJ); Rita Marie Guerrero (Hillsborough, NJ)
Assignee: ISP INVESTMENTS INC.
A61K8/8182A61K8/062A61K8/35A61K8/37A61K8/375A61K8/40A61K8/604A61Q17/04A61K2800/30A61K2800/596
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,214,067
App. No.
15/115,479
Granted
Feb 4, 2025
Kind
B2
Abstract

In accordance with the present invention there is provided an oil-in-water emulsion sunscreen composition comprising (a) a UV active, (b) a first emulsifier having an HLB value less than 5 and (c) optionally a second emulsifier having an HLB value greater than 5 present in an amount of less than 0.2% w/w of the composition. The oil-in-water sunscreen composition is characterized by the absence of an emulsifiable polymer and is capable of providing little to no whitening when applied to wet skin.

Claims (16)

1. An oil-in-water emulsion wet-skin sunscreen composition consisting of:

(a) one or more UV actives,

(b) 0.1% w/w to about 5% w/w of a first emulsifier having an HLB value less than 5, wherein the first emulsifier may be comprised of one emulsifier compound or a combination of emulsifier compounds,

(c) a second emulsifier having an HLB value greater than 5, wherein the second emulsifier is present in an amount from about 0.05% w/w to about 0.2% w/w of said composition, and may be comprised of one emulsifier compound or a combination of emulsifier compounds;

(d) one or more film forming and/or water proofing agents selected from the group consisting of poly (butylated vinylpyrrolidone), vinylpyrrolidone and hexadecene copolymer, vinylpyrrolidone and eicosene copolymer, vinyl pyrrolidone and 1-triacontane copolymer, acrylates/C 12 -C 22 alkylmethacrylate copolymer, acrylic acid/vinylpyrrolidone crosspolymer, and blends thereof,

(e) one or more ingredients selected from the group consisting of skin-feel additives, pH adjusters, chelating agents, exfoliating agents, treatment agents, fragrances, emollients, liquid carriers, waxes, conditioners, surfactants, rheology modifiers, lubricants, diluents, humectants, antibiotics, viscosity synergists, clarity synergists, antioxidants, anti-aging ingredients, moisturizing agents, preservatives and blends thereof, and

(f) water;

wherein said oil-in-water wet-skin sunscreen composition is free of an emulsifiable polymer, which is defined as a polymer containing hydrophobic chains and causing flaking and/or whitening upon application to wet skin;

wherein the first emulsifier is selected from the group consisting of glycol distearate, sorbitan trioleate, glycol stearate, sorbitan sesquioleate, glyceryl stearate, glyceryl dilaurate, lecithin, sorbitan oleate, sorbitan stearate, sorbitan isostearate, oleth-2 and steareth-2, and blends thereof; and

wherein the second emulsifier is selected from the group consisting of calcium stearoyl lactylate, glyceryl laurate, ceteth-2, PEG-30 dipolyhydroxystearate, glyceryl stearate SE, PEG-4 dilaurate, sorbitan stearate (and) sucrose cocoate, methyl glucose sesquistearate, sucrose stearate, PEG-10 sunflower glycerides, sodium stearoyl lactylate, sorbitan laurate, PEG-40 sorbitan peroleate, lecithin, laureth-4, PEG-7 glyceryl cocoate, PEG-20 almond glycerides, linoleamide DEA, PEG-25 hydrogenated castor oil, cetearyl glucoside, polysorbate 85, glyceryl stearate (and) PEG-100 stearate, stearamide MEA, oleth-10/polyoxyl 10 oleyl ether NF, oleth-10, oleth-20, ceteth-10, PEG-8 laurate, cocamide MEA, polysorbate 60, PEG-60 almond glycerides, isosteareth-20, lauramide DEA, PEG-30 dipolyhydroxystearate, polysorbate 80, PEG-20 methyl glucose sesquistearate, ceteareth-20, oleth-20, steareth-21, ceteth-20, isoceteth-20, polysorbate 20, laureth-23, PEG-100 stearate, PEG-80 sorbitan laurate and blends thereof.

2. The composition of claim 1 wherein said one or more UV actives is selected from the group consisting of UV-A and/or UV-B actives.

3. The composition of claim 1 , wherein the

second emulsifier is selected from the group consisting of PEG-4 dilaurate, sorbitan stearate (and) sucrose cocoate, methyl glucose sesquistearate, PEG-10 sunflower glycerides, sodium stearoyl lactylate, sorbitan laurate, and blends thereof.

4. The composition of claim 1 , wherein said one or more UV actives is selected from the group consisting of: methoxydibenzoylmethane; octyl salicylate; pentyl dimethyl PABA; octyl dimethyl PABA; benzophenone-1; benzophenone-6; 2-(2H-benzotriazole-2-yl)-4,6-di-tert-pentylphenol; ethyl-2-cyano-3,3-diphenylacrylate; homomethyl salicylate (homosalate); bis-ethylhexyloxyphenol methoxyphenyl triazine; methyl-(1,2,2,6,6-pentamethyl-4-piperidyl)-sebacate; 2-(2H-benzotriazole-2-yl)-4-methylphenol; diethylhexyl butamido triazone; amyl dimethyl PABA; 4,6-bis (octylthiomethyl)-o-cresol; red petroleum; ethylhexyl triazone; octocrylene; isoamyl-p-methoxycinnamate; drometrizole; titanium dioxide; 2,4-di-tert-butyl-6-(5-chloro-2H-benzotriazole-2-yl)-phenol;2-hydroxy-4-octyloxybenzophenone; benzophenone-2; diisopropyl methylcinnamate; PEG-25 PABA; 2-(1,1-dimethylethyl)-6-[[3-(1,1-demethylethyl)-2-hydroxy-5-methylphenyl]methyl-4-methylphenyl acrylate; drometrizole trisiloxane; menthyl anthranilate; butyl methoxydibenzoylmethane; 2-ethoxyethyl p-methoxycinnamate; benzylidene camphor sulfonic acid; dimethoxyphenyl-[1-(3,4)]-4,4-dimethyl 1,3-pentanedione; zinc oxide; N,N′-hexane-1,6-diylbis [3-(3,5-di-tert-butyl-4-hydroxyphenylpropionamide)]; pentaerythritol tetrakis [3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate];2,6-di-tert-butyl-4-[4,6-bis(octylthio)-1,3,5-triazin-2-ylaminolphenol; 2-(2H-benzotriazole-2-yl)-4,6-bis(1-methyl-1-phenylethyl) phenol; trolamine salicylate; diethylanolamine p-methoxycinnamate; polysilicone-15; 4-methylbenzylidene camphor; bisoctrizole; N-phenyl-benzenamine; reaction products with 2,4,4-trimethylpentene; sulisobenzone; (2-ethylhexyl)-2-cyano-3,3-diphenylacrylate; digalloyl trioleate; polyacrylamido methylbenzylidene camphor; glyceryl ethylhexanoate dimethoxycinnamate; 1,3-bis-[(2′-cyano-3′,3′-diphenylacryloyl)oxy}-2,2-bis-[(2′-cyano-bis-(2,2,6,6-tetramethyl-4-piperidyl)-sebacate; benzophenone-5; 1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione; hexamethylendiamine; benzophenone-8; ethyl-4-bis(hydroxypropyl)aminobenzoate; 6-tert-butyl-2-(5-chloro-2H-benzotriazole-2-yl)-4-methylphenol; p-aminobenzoic acid; 3,3′,3″, 5,5′,5″-hexa-tert-butyl-α-α′-α″-(mesitylene-2,4,6-triyl)tri-p-cresol; lawsone with dihydroxyacetone; benzophenone-9; benzophenone-4; ethylhexyl dimethoxy benzylidene dioxoimidazoline propionate; N,N′-bisformyl-N,N′-bis-(2,2,6,6-tetramethyl-4-piperidinyl)-; 3-benzylidene camphor; terephthalylidene dicamphor sulfonic acid; camphor benzalkonium methosulfate; bisdisulizole disodium; etocrylene; ferulic acid;2-(2H-benzotriazole-2-yl)-4-(1,1,3,3-tetramethylbutyl)-phenol; 4,6-bis(dodecylthiomethyl)-o-cresol; β-2-glucopyranoxy propyl hydroxy benzophenone; phenylbenzimidazole sulfonic acid; benzophenone-3; diethylamine hydroxybenzoyl hexylbenzoate; 3′,3″-diphenylacryloyl)oxy]methyl}-propane; ethylhexyl p-methoxycinnamate, and blends thereof.

5. The composition of claim 4 , wherein said one or more UV actives is selected from the group consisting of homomenthyl salicylate (homosalate), octisalate, avobenzone, oxybenzone, octocrylene, and blends thereof.

6. The composition of claim 1 , wherein said one or more UV actives is present in an amount of 0.1 to 50% w/w of the total composition.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2020
From: THE BANK OF NOVA SCOTIA
To: AVOCA LLC; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES LLC
Reel/Frame 051557/0504 →
SECURITY AGREEMENT Recorded Jul 3, 2017
From: AVOCA, INC.; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES, INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 043084/0753 →
CHANGE OF NAME Recorded May 24, 2017
From: ISP INVESTMENTS INC.
To: ISP INVESTMENTS LLC
Reel/Frame 042560/0842 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2016
From: KENNEDY, DIANNE M.; PRETTYPAUL, DONALD I.; FARES, HANI M.; GUERRERO, RITA MARIE
To: ISP INVESTMENTS INC.
Reel/Frame 039293/0398 →
Continuity (2)
Provisional Application 61934158 · Jan 31, 2014
Related Publication 20170165187A1 · Jun 15, 2017
References Cited (13)
US 4917883A · Strobridge · 1990 [cited by examiner]
US 5730993A · Allard · 1998 [cited by examiner]
US 5733531A · Mitchnick · 1998 [cited by examiner]
US 20010022966A1 · Gers-Barlag · 2001 [cited by examiner]
US 20010047039A1 · McManus · 2001 [cited by examiner]
US 20030049214A1 · Muller · 2003 [cited by applicant]
US 20030059391A1 · L'Alloret · 2003 [cited by examiner]
US 20110014139A1 · Viala · 2011 [cited by examiner]
US 20110236498A1 · Marteaux et al. · 2011 [cited by applicant]
US 20130164232A1 · Castro · 2013 [cited by examiner]
WO WO2009038710A2 · 2009 [cited by applicant]
WO WO2012149355A1 · 2012 [cited by applicant]
International Search Report, PCT/US2015/013689 published on Aug. 6, 2015. [cited by applicant]